--- title: "Assessing China Tower (SEHK:788) Valuation After First Quarter Earnings Lift Investor Interest" type: "News" locale: "en" url: "https://longbridge.com/en/news/283261389.md" description: "China Tower (SEHK:788) reported Q1 2026 sales of CN¥25,146 million and net income of CN¥3,985 million, showing growth from the previous year. The stock is currently priced at HK$11.03, with a fair value estimate of HK$13.42, indicating it may be undervalued. The company is diversifying into new business areas, but risks remain regarding profitability and capital allocation. Investors are advised to consider the underlying data and potential risks before making decisions. This analysis does not constitute financial advice." datetime: "2026-04-19T17:46:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283261389.md) - [en](https://longbridge.com/en/news/283261389.md) - [zh-HK](https://longbridge.com/zh-HK/news/283261389.md) --- # Assessing China Tower (SEHK:788) Valuation After First Quarter Earnings Lift Investor Interest ## Why China Tower’s latest earnings matter for investors China Tower (SEHK:788) reported first quarter 2026 sales of CN¥25,146 million and net income of CN¥3,985 million, compared with CN¥24,771 million and CN¥3,024 million a year earlier, drawing fresh attention to the stock. See our latest analysis for China Tower. Following the earnings release and the proposed share issuance mandate, the share price at HK$11.03 has a 1 year total shareholder return of 5.13% and a 3 year total shareholder return of 28.96%, while recent short term share price returns have softened. If you are looking beyond a single telecom infrastructure name, this is a good moment to see how the sector connects to data centers, towers and grid upgrades through 31 power grid technology and infrastructure stocks With China Tower trading at HK$11.03, carrying an intrinsic discount flag and a 1 year total return of 5.13% alongside 3 year returns just under 29%, is this a genuine mispricing or has the market already accounted for future growth? ## Most Popular Narrative: 17.8% Undervalued With China Tower’s fair value estimate at HK$13.42 versus the HK$11.03 last close, the widely followed narrative leans toward a valuation gap that hinges on how new revenue streams develop. > _The company is investing heavily in diversifying into Two Wings businesses (Smart Tower, Energy), but these segments have yet to reach scale and their long-term profitability and margin contribution remain uncertain. This introduces risks of capital misallocation and downward pressure on group net margins if these initiatives fail to deliver robust returns. Despite improved cost efficiency (lower OpEx, maintenance, depreciation), continued flat or declining operator demand for traditional towers and increasing reliance on value-added businesses could place pressure on net margins if these new businesses do not offset stagnation or declines in the core business over time._ Read the complete narrative. Curious what assumptions have to line up for that HK$13.42 fair value, the projected revenue lift, margin shift, and future earnings multiple all pull in the same direction. The narrative uses a discount rate of 7.81%, bakes in modest top line growth and higher profit margins, and then applies a future earnings multiple that is lower than the current P/E for the Hong Kong telecom industry. Together, these produce an equity value above today’s share price. **Result: Fair Value of HK$13.42 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, flat core tower revenue and uncertain returns from the Two Wings expansion could still challenge the idea that today’s discount reflects a clear opportunity. Find out about the key risks to this China Tower narrative. ## Next Steps Given the mix of optimism and concern running through this story, it makes sense to look at the underlying data now and decide where you stand. Start with the 4 key rewards and 1 important warning sign. ## Looking for more investment ideas? If China Tower has sharpened your thinking, now is the time to widen your watchlist with other clear, data backed ideas before the next move happens. - Target dependable income by reviewing companies that qualify as 479 dividend fortresses and see which yields stand out to you. - Hunt for price gaps by scanning the 233 high quality undervalued stocks and spot names where fundamentals and market pricing look out of sync. - Prioritise resilience by focusing on businesses in the 300 resilient stocks with low risk scores and build a shortlist that aims to keep portfolio swings in check. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** AI Stock Screener & Alerts Our new AI Stock Screener scans the market every day to uncover opportunities. • Dividend Powerhouses (3%+ Yield) • Undervalued Small Caps with Insider Buying • High growth Tech and AI Companies Or build your own from over 50 metrics. Explore Now for Free ### Related Stocks - [00788.HK](https://longbridge.com/en/quote/00788.HK.md) ## Related News & Research - [China Tower Sets 2025 AGM to Approve Results, Dividend and Share-Issuance Mandate](https://longbridge.com/en/news/283124218.md) - [China Tower (SEHK:788) Margin Improvement Outpaces Modest Revenue Growth And Tests Bearish Narratives](https://longbridge.com/en/news/279766892.md) - [CICC Reaffirms Their Buy Rating on China Tower (CHWRF)](https://longbridge.com/en/news/279890263.md) - [Lepu Biopharma Exits Biotech Marker Regime After Meeting HKEX Mainboard Tests](https://longbridge.com/en/news/285380638.md) - [13:07 ETRapid Relief Team to Honor Nurses Across North America with Month-Long International Nurses Day Events](https://longbridge.com/en/news/285242731.md)